{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:14:20Z","timestamp":1788527660056,"version":"build-2803163510"},"reference-count":32,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"SK Bioscience","award":["Q208731"],"award-info":[{"award-number":["Q208731"]}]},{"award":["Q208731"],"award-info":[{"award-number":["Q208731"]}],"id":[{"id":"https:\/\/ror.org\/0180de293","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Human papillomavirus (HPV) genotype distribution is an important epidemiologic indicator for guiding public health surveillance, yet large-scale, laboratory-based data among Korean females remain limited, particularly following the incorporation of HPV vaccination into the National Immunization Program in 2016. This study evaluated HPV positivity and genotype distribution among clinically tested Korean females using a large-scale laboratory-based dataset. Methods: A retrospective analysis was conducted on 530,808 HPV genotyping results from Korean females tested between 2014 and 2022 using the Anyplex\u2122 II HPV 28 Detection system (Seegene, Seoul, Republic of Korea). Specimens were classified as high-risk (HR), low-risk (LR), or multiple-type infections, and the proportion of specimens containing at least one HR genotype not included in the 9-valent vaccine was determined. Results: The overall HPV positivity rate was 44.4%, with a U-shaped age distribution. HPV 52 was the most frequently detected genotype (7.2%), followed by HPV 53 (6.3%) and HPV 58 (5.1%). Multiple-type infections were identified in 45.4% of HPV-positive specimens, and 24.4% of specimens harbored at least one HR genotype not included in the 9-valent vaccine. Conclusions: This large-scale laboratory-based analysis provides updated epidemiologic data on HPV positivity and genotype distribution among clinically tested Korean females. As this cohort reflects clinically tested rather than population-based specimens, these findings should be interpreted as descriptive observations that support continued surveillance of circulating HPV genotypes.<\/jats:p>","DOI":"10.3390\/jcm15176853","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:20:46Z","timestamp":1788524446000},"page":"6853","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human Papillomavirus Positivity and Genotype Distribution Among Korean Females: A Large-Scale Laboratory-Based Analysis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3976-2721","authenticated-orcid":false,"given":"Jae Hyun","family":"Baik","sequence":"first","affiliation":[{"name":"Department of Urology, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Mi Mi","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Urology, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7393-2936","authenticated-orcid":false,"given":"Seon Beom","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Urology, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9031-9845","authenticated-orcid":false,"given":"Du Geon","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Urology, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kombe Kombe, A.J., Li, B., Zahid, A., Mengist, H.M., Bounda, G.-A., Zhou, Y., and Jin, T. (2021). Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front. Public Health, 8.","DOI":"10.3389\/fpubh.2020.552028"},{"key":"ref_2","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2007). Human Papillomaviruses, International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans."},{"key":"ref_3","unstructured":"World Health Organization (2022). Human Papillomavirus Vaccines: WHO Position Paper, December 2022. Wkly. Epidemiol. Rec., 97, 645\u2013672."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women","volume":"372","author":"Joura","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.ejca.2015.06.001","article-title":"Human Papillomavirus Genotype Attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in Female Anogenital Lesions","volume":"51","author":"Serrano","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-Level Impact and Herd Effects Following the Introduction of Human Papillomavirus Vaccination Programmes: Updated Systematic Review and Meta-Analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human Papillomavirus Genotype Attribution in Invasive Cervical Cancer: A Retrospective Cross-Sectional Worldwide Study","volume":"11","author":"Quint","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"Worldwide Distribution of Human Papillomavirus Types in Cytologically Normal Women in the International Agency for Research on Cancer HPV Prevalence Surveys: A Pooled Analysis","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e2023076","DOI":"10.4178\/epih.e2023076","article-title":"Parental Intention to Vaccinate Daughters with the Human Papillomavirus Vaccine in Korea: A Nationwide Cross-Sectional Survey","volume":"45","author":"Ha","year":"2023","journal-title":"Epidemiol. Health"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1086\/421279","article-title":"Prevalence and Determinants of Genital Infection with Papillomavirus, in Female and Male University Students in Busan, South Korea","volume":"190","author":"Shin","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.3802\/jgo.2018.29.e14","article-title":"Prevalence of Human Papillomavirus Genotypes and Precancerous Cervical Lesions in a Screening Population in the Republic of Korea, 2014\u20132016","volume":"29","author":"Ouh","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.15430\/JCP.2016.21.2.104","article-title":"Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea","volume":"21","author":"So","year":"2016","journal-title":"J. Cancer Prev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12985-025-02902-8","article-title":"Diagnostic Criteria for HPV Infection Classification: A Comment on Wen et al","volume":"22","year":"2025","journal-title":"Virol. J."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Arroyo, L.S., Basaras, M., Arrese, E., Hern\u00e1ez, S., Esteban, V., and Cisterna, R. (2016). Distribution of Genital Human Papillomavirus Genotypes in Benign Clinical Manifestations among Men from Northern Spain. BMC Public Health, 16.","DOI":"10.1186\/s12889-016-2713-x"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5468\/OGS.2013.56.2.110","article-title":"Type-Specific Prevalence of High-Risk Human Papillomavirus by Cervical Cytology and Age: Data from the Health Check-Ups of 7,014 Korean Women","volume":"56","author":"Kim","year":"2013","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chan, P.K.S., Ho, W.C.S., Chan, M.C.W., Wong, M.C.S., Yeung, A.C.M., Chor, J.S.Y., and Hui, M. (2014). Meta-Analysis on Prevalence and Attribution of Human Papillomavirus Types 52 and 58 in Cervical Neoplasia Worldwide. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107573"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3346\/jkms.2012.27.9.1091","article-title":"Prevalence and Distribution of Human Papillomavirus Infection in Korean Women as Determined by Restriction Fragment Mass Polymorphism Assay","volume":"27","author":"Lee","year":"2012","journal-title":"J. Korean Med. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kim, J.M., Song, H.S., Hwang, J., and Kim, J.K. (2025). The Prevalence of Multi-Type Infections Among Human Papillomavirus Types in Korean Women. Pathogens, 14.","DOI":"10.3390\/pathogens14040369"},{"key":"ref_20","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2012). Biological Agents, International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Song, H., Lee, S., Choi, S., and Hur, S.Y. (2025). Effectiveness of the Human Papillomavirus Vaccine in Extended Age Groups: A Real-World Analysis Based on the Korean HPV Cohort Study. Cancers, 17.","DOI":"10.3390\/cancers17152561"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","article-title":"Epidemiologic Profile of Type-Specific Human Papillomavirus Infection and Cervical Neoplasia in Guanacaste, Costa Rica","volume":"191","author":"Herrero","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.3802\/jgo.2025.36.e7","article-title":"Prevalence of High-Risk Human Papillomavirus Genotypes among Women in Uzbekistan, 2021\u20132023","volume":"36","author":"Sharipova","year":"2025","journal-title":"J. Gynecol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1086\/324579","article-title":"Cervical Coinfection with Human Papillomavirus (HPV) Types as a Predictor of Acquisition and Persistence of HPV Infection","volume":"184","author":"Rousseau","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/587698","article-title":"Type-Specific Duration of Human Papillomavirus Infection: Implications for Human Papillomavirus Screening and Vaccination","volume":"197","author":"Trottier","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/infdis\/jiq139","article-title":"Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease","volume":"203","author":"Chaturvedi","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.22241","article-title":"Variations in the Age-specific Curves of Human Papillomavirus Prevalence in Women Worldwide","volume":"119","author":"Franceschi","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.otc.2012.04.005","article-title":"Biology of Human Papillomavirus Infection and Immune Therapy for HPV-Related Head and Neck Cancers","volume":"45","author":"Best","year":"2012","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1172\/JCI57149","article-title":"The Known Unknowns of HPV Natural History","volume":"121","author":"Gravitt","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/ijc.27828","article-title":"Patterns of Persistent Genital Human Papillomavirus Infection among Women Worldwide: A Literature Review and Meta-Analysis","volume":"133","author":"Rositch","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4111\/icu.20250223","article-title":"Prevalence and Genotype Distribution of Human Papillomavirus among Korean Males: Implications for Vaccination Strategies","volume":"67","author":"Jo","year":"2026","journal-title":"Investig. Clin. Urol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vaccine.2013.10.085","article-title":"Reduction in HPV 16\/18 Prevalence in Sexually Active Young Women Following the Introduction of HPV Immunisation in England","volume":"32","author":"Mesher","year":"2013","journal-title":"Vaccine"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6853\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:25:14Z","timestamp":1788524714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":32,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15176853"],"URL":"https:\/\/doi.org\/10.3390\/jcm15176853","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]}}}